These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34190825)

  • 21. Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity.
    Simkins T; Crawford RB; Goudreau JL; Lookingland KJ; Kaplan BL
    J Neuroimmune Pharmacol; 2014 Sep; 9(4):544-57. PubMed ID: 24870806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice Missing Cnr1 and Cnr2 Show Implantation Defects.
    Li Y; Bian F; Sun X; Dey SK
    Endocrinology; 2019 Apr; 160(4):938-946. PubMed ID: 30776303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular biology of cannabinoid receptors.
    Abood ME
    Handb Exp Pharmacol; 2005; (168):81-115. PubMed ID: 16596772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia.
    Chavarría-Siles I; Contreras-Rojas J; Hare E; Walss-Bass C; Quezada P; Dassori A; Contreras S; Medina R; Ramírez M; Salazar R; Raventos H; Escamilla MA
    Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):279-84. PubMed ID: 18186055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptor gene CNR1 is downregulated in subcortical brain samples and upregulated in blood samples of individuals with schizophrenia: A participant data systematic meta-analysis.
    Bloch Priel S; Yitzhaky A; Gurwitz D; Hertzberg L
    Eur J Neurosci; 2023 Sep; 58(6):3540-3554. PubMed ID: 37611908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid receptor 1/2 double-knockout mice develop epilepsy.
    Rowley S; Sun X; Lima IV; Tavenier A; de Oliveira ACP; Dey SK; Danzer SC
    Epilepsia; 2017 Dec; 58(12):e162-e166. PubMed ID: 29105060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain cannabinoid CB2 receptor in schizophrenia.
    Ishiguro H; Horiuchi Y; Ishikawa M; Koga M; Imai K; Suzuki Y; Morikawa M; Inada T; Watanabe Y; Takahashi M; Someya T; Ujike H; Iwata N; Ozaki N; Onaivi ES; Kunugi H; Sasaki T; Itokawa M; Arai M; Niizato K; Iritani S; Naka I; Ohashi J; Kakita A; Takahashi H; Nawa H; Arinami T
    Biol Psychiatry; 2010 May; 67(10):974-82. PubMed ID: 19931854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders].
    Martínez-Gras I; Hoecnika J; Pérez-Hernández E; Rodríguez-Jiménez R; Ponce G; Jiménez-Arriero M; Ramos-Atance J; Palomo T; Rubio G
    Actas Esp Psiquiatr; 2007; 35(2):122-9. PubMed ID: 17401783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia.
    Ujike H; Morita Y
    J Pharmacol Sci; 2004 Dec; 96(4):376-81. PubMed ID: 15613777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets.
    Aghamahdi F; Shafiee A; Rostami S; Mokhames Z; Safavi M; Yaslianifard S; Siami Z; Kabir K; Azizi G; Bakhtiyari M; Mozhgani SH
    Diabetes Metab Syndr; 2022 May; 16(5):102499. PubMed ID: 35580523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia.
    Tao R; Li C; Jaffe AE; Shin JH; Deep-Soboslay A; Yamin R; Weinberger DR; Hyde TM; Kleinman JE
    Transl Psychiatry; 2020 May; 10(1):158. PubMed ID: 32433545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.
    Hamdani N; Tabeze JP; Ramoz N; Ades J; Hamon M; Sarfati Y; Boni C; Gorwood P
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):34-40. PubMed ID: 17669634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of functional cannabinoid receptors in human endocrine pancreas.
    Bermúdez-Silva FJ; Suárez J; Baixeras E; Cobo N; Bautista D; Cuesta-Muñoz AL; Fuentes E; Juan-Pico P; Castro MJ; Milman G; Mechoulam R; Nadal A; Rodríguez de Fonseca F
    Diabetologia; 2008 Mar; 51(3):476-87. PubMed ID: 18092149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals.
    Tsuchimine S; Yasui-Furukori N; Kaneda A; Kaneko S
    PLoS One; 2013; 8(11):e76763. PubMed ID: 24282499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?
    Balzan RP; Neaves A; Denson LA; Liu D; Galletly C
    Cogn Neuropsychiatry; 2014; 19(6):471-84. PubMed ID: 24749790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population.
    Martínez-Gras I; Hoenicka J; Ponce G; Rodríguez-Jiménez R; Jiménez-Arriero MA; Pérez-Hernandez E; Ampuero I; Ramos-Atance JA; Palomo T; Rubio G
    Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):437-41. PubMed ID: 16788767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daytime-Dependent Changes of Cannabinoid Receptor Type 1 and Type 2 Expression in Rat Liver.
    Bazwinsky-Wutschke I; Zipprich A; Dehghani F
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact Hypersensitivity.
    Gaffal E; Kemter AM; Scheu S; Leite Dantas R; Vogt J; Baune B; Tüting T; Zimmer A; Alferink J
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome.
    Wasilewski A; Lewandowska U; Mosinska P; Watala C; Storr M; Fichna J; Venkatesan T
    Am J Gastroenterol; 2017 Jun; 112(6):933-939. PubMed ID: 28349993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression and functional role of cannabinoid genes in alcohol users.
    Agudelo M; Yndart A; Morrison M; Figueroa G; Muñoz K; Samikkannu T; Nair MP
    Drug Alcohol Depend; 2013 Dec; 133(2):789-93. PubMed ID: 24060590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.